ARIMIDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Arimidex, and what generic alternatives are available?
Arimidex is a drug marketed by Ani Pharms and is included in one NDA.
The generic ingredient in ARIMIDEX is anastrozole. There are twenty-four drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the anastrozole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Arimidex
A generic version of ARIMIDEX was approved as anastrozole by ACCORD HLTHCARE on June 28th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARIMIDEX?
- What are the global sales for ARIMIDEX?
- What is Average Wholesale Price for ARIMIDEX?
Summary for ARIMIDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Clinical Trials: | 152 |
Drug Prices: | Drug price information for ARIMIDEX |
What excipients (inactive ingredients) are in ARIMIDEX? | ARIMIDEX excipients list |
DailyMed Link: | ARIMIDEX at DailyMed |
Recent Clinical Trials for ARIMIDEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Washington | Phase 2 |
Breast Cancer Research Foundation | Phase 2 |
European Network of Gynaecological Oncological Trial Groups (ENGOT) | Phase 3 |
Pharmacology for ARIMIDEX
Drug Class | Aromatase Inhibitor |
Mechanism of Action | Aromatase Inhibitors |
US Patents and Regulatory Information for ARIMIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | ARIMIDEX | anastrozole | TABLET;ORAL | 020541-001 | Dec 27, 1995 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ARIMIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | ARIMIDEX | anastrozole | TABLET;ORAL | 020541-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ARIMIDEX | anastrozole | TABLET;ORAL | 020541-001 | Dec 27, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ARIMIDEX
See the table below for patents covering ARIMIDEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 97804 | ⤷ Sign Up | |
United Kingdom | 8714013 | ⤷ Sign Up | |
New Zealand | 225037 | SUBSTITUTED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ARIMIDEX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0296749 | 09C0055 | France | ⤷ Sign Up | PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME DUN SEL DADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; REGISTRATION NO/DATE IN FRANCE: NL 21126 DU 19961227; REGISTRATION NO/DATE AT EEC: 12619/0106 DU 19950811 |
0296749 | SPC/GB96/004 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ANASTROZOLE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT; REGISTRATION NO/DATE: UK 12619/0106 19950811 |
0296749 | 97C0023 | France | ⤷ Sign Up | PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D UN SEL D ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; NAT REG. NO/DATE: NL 21126 19961227; FIRST REG.: 12619/0106 19950811 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |